Form D Explorer

Inspect source fieldsReport a record issue

Form D — Aeovian Pharmaceuticals, Inc.

0000905148-25-004456 · filed Dec 22, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$54,999,996
Reported amount sold
$54,999,996
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Aeovian Pharmaceuticals, Inc.
CIK
1710088
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
2930 Domingo Ave., Suite 145
Berkeley, California 94705
Phone
510-961-1148

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗